CDK10 and colorectal cancer: In the present study, CDK12 overexpression was associated with higher survival rate, while patients with downregulated expression of CDK10 and 16 exhibited lower OS, suggesting that CDK10/16 and CDK12 can be used as prognostic biomarkers for colorectal cancer patients.